Virtual Reality Exposure and Respiratory Relaxation-Based Coping With Cocaine Craving in Cocaine Users
NCT ID: NCT05557149
Last Updated: 2022-09-27
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
NA
11 participants
INTERVENTIONAL
2021-03-31
2021-07-29
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Benefits of Therapy With Virtual Reality Exposure in the Treatment of Cocaine Use Disorders
NCT04280900
Innovative Cognitive and Behavioral Psychotherapy for Cocaine Use Disorder
NCT05833529
Cocaine Cue-reactivity Incubation Study
NCT07091877
Developing Computer Based Treatments for Addiction
NCT00586534
Transcranial Direct Current Stimulation (tDCS) for Treatment of Cocaine Use Disorder
NCT07318480
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
NON_RANDOMIZED
CROSSOVER
BASIC_SCIENCE
NONE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Neutral VR
Ten minutes virtual reality exposure to neutral stimuli (e.g. neutral picture frames)
Virtual Reality Exposure to Neutral Cues
Virtual reality exposure to neutral stimuli (360 degrees visual and audio immersion with Oculus Quest 2 virtual reality headset). Participants stay sitted on chair and can tilt, rotate and move forward and backward upper body members. No interaction with the investigator during the virtual reality immersion.
Cocaine VR
Ten minutes virtual reality exposure to cocaine use-related stimuli (i.e. peers using cocaine, cocaine paraphernalia, cocaine use preparing, cocaine use, etc.)
Virtual Reality Exposure to Cocaine-Related Cues
Virtual reality exposure to cocaine-related stimuli (360 degrees visual and audio immersion with Oculus Quest 2 virtual reality headset). Participants stay sitted on chair and can tilt, rotate and move forward and backward upper body members. No interaction with the investigator during the virtual reality immersion.
Relaxation
Ten minutes respiratory relaxation (eyes closed and sitted on a chair)
Respiratory Relaxation
Respiratory relaxation practise. No interaction with the investigator during the relaxation practise.
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Virtual Reality Exposure to Neutral Cues
Virtual reality exposure to neutral stimuli (360 degrees visual and audio immersion with Oculus Quest 2 virtual reality headset). Participants stay sitted on chair and can tilt, rotate and move forward and backward upper body members. No interaction with the investigator during the virtual reality immersion.
Respiratory Relaxation
Respiratory relaxation practise. No interaction with the investigator during the relaxation practise.
Virtual Reality Exposure to Cocaine-Related Cues
Virtual reality exposure to cocaine-related stimuli (360 degrees visual and audio immersion with Oculus Quest 2 virtual reality headset). Participants stay sitted on chair and can tilt, rotate and move forward and backward upper body members. No interaction with the investigator during the virtual reality immersion.
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
Exclusion Criteria
* Actual psychotic episode (MINI, Lecrubier and al., 1998)
* Actual high suicidal risk (MINI, Lecrubier and al., 1998)
* Being involved in incarceration procedure
* Medical risk for safety while physiological arousal (e.g. cardiac disease)
* Disability for performing virtual reality task (e.g. blindness or deafness)
* Significant motion sickness symptoms (SSQ pre-post total score ≥ 15, Bimberg et al., 2020)
18 Years
ALL
Yes
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
ICube Laboratory - Team IGG
UNKNOWN
Ithaque Association
UNKNOWN
University Hospitals of Strasbourg
UNKNOWN
University Hospital, Strasbourg, France
OTHER
The French National Cancer Institute
UNKNOWN
The French Institute for Public Health Research
UNKNOWN
Laboratoire de Psychologie des Cognitions
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Thomas Lehoux
Ph.D. Candidate
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Thomas Lehoux, Ph.D. Candidate
Role: PRINCIPAL_INVESTIGATOR
Laboratoire de Psychologie des Cognitions (Strasbourg University)
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Laboratoire de Psychologie des Cognitions (Strasbourg University)
Strasbourg, Bas-Rhin, France
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
AAC21-SPA-04
Identifier Type: OTHER_GRANT
Identifier Source: secondary_id
2021-A00242-39
Identifier Type: OTHER
Identifier Source: secondary_id
21.02.14.82513
Identifier Type: OTHER
Identifier Source: secondary_id
RVCOC2021
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.